Associations of Coagulation Factor V Leiden and Prothrombin G20210A Mutations With Budd–Chiari Syndrome and Portal Vein Thrombosis: A Systematic Review and Meta-analysis
- 1 November 2014
- journal article
- review article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 12 (11) , 1801-1812.e7
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controlsEuropean Journal of Epidemiology, 2013
- Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta‐analysis of the literatureJournal of Thrombosis and Haemostasis, 2012
- 180 CLINICAL AND GENETIC FACTORS ASSOCIATED TO DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS WITHOUT HEPATOCELLULAR CARCINOMAJournal of Hepatology, 2011
- Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort studyHaematologica, 2009
- Vascular disorders of the liver # †Hepatology, 2009
- Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosisJournal of Hepatology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationNew England Journal of Medicine, 1999
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986